VERY EARLY MOLECULAR RESPONSE AT 1 MONTH CAN PREDICT 12-MONTH MAJOR MOLECULAR RESPONSE IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA TREATED WITH TKIS

被引：0
|
作者：
Song, H. Y. [1 ]
Choi, S. Y. [1 ]
Lee, S. E. [1 ,2 ]
Kim, S. H. [1 ]
Yoo, H. L. [1 ]
Lee, M. Y. [1 ]
Hwang, H. J. [1 ]
Kang, K. H. [1 ]
Kee, K. M. [1 ]
Kim, D. W. [1 ,2 ]
机构：
[1] Catholic Univ Korea, Catholic Leukemia Res Inst, Seoul, South Korea
[2] Catholic Univ Korea, Dept Hematol, Seoul St Marys Hosp, Seoul, South Korea
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1103
引用
收藏
页码：456 / 456
页数：1
相关论文
共 50 条
  • [31] Impact Of Major Molecular Response On Overall Survival and Its Time Of Achievement On Complete Molecular Response Incidence In Chronic Myeloid Leukemia Patients Treated By Tyrosine Kinase Inhibitors In First Chronic Phase
    Michallet, Mauricette
    Sobh, Mohamad
    Labussiere, Helene
    Gilis, Lila
    Barraco, Fiorenza
    Etienne, Madeleine
    Le Borgne, Oriane
    Tigaud, Isabelle
    Hayette, Sandrine
    Ducastelle, Sophie
    Thomas, Xavier
    BLOOD, 2013, 122 (21)
  • [32] LONG TERM MOLECULAR RESPONSE IN IMATINIB TREATED CHRONIC MYELOID LEUKEMIA PATIENTS
    Jovanovic, V.
    Bogdanovic, D.
    Djordjevic, A.
    Dencic-Fekete, S.
    Gotic, D.
    HAEMATOLOGICA, 2012, 97 : 542 - 542
  • [33] Standardized definitions of molecular response in chronic myeloid leukemia
    N C P Cross
    H E White
    M C Müller
    G Saglio
    A Hochhaus
    Leukemia, 2012, 26 : 2172 - 2175
  • [34] Nivolumab to control molecular response in chronic myeloid leukemia
    Rousselot, Philippe
    Renard, Perrine
    de Buyer, Ariane
    Finet, Adeline
    Spentchian, Marc
    Saiag, Philippe
    LEUKEMIA RESEARCH, 2018, 72 : 5 - 6
  • [35] Standardized definitions of molecular response in chronic myeloid leukemia
    Cross, N. C. P.
    White, H. E.
    Mueller, M. C.
    Saglio, G.
    Hochhaus, A.
    LEUKEMIA, 2012, 26 (10) : 2172 - 2175
  • [36] Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
    Yeung, David T.
    Mauro, Michael J.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 240 - 243
  • [37] CLINICAL SIGNIFICANCE OF EARLY MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH IMATINIB MESYLATE
    Castagnetti, F.
    Gugliotta, G.
    Breccia, M.
    Albano, F.
    Abruzzese, E.
    Levato, L.
    Cavazzini, F.
    Lurlo, A.
    Stagno, F.
    Ferrero, D.
    Porretto, F.
    Martino, B.
    Rupoli, S.
    Intermesoli, T.
    Fava, C.
    Pierri, I.
    Palandri, F.
    Venturi, C.
    Soverini, S.
    Luatti, S.
    Alimena, G.
    Pane, F.
    Martinelli, G.
    Saglio, G.
    Cavo, M.
    Baccarani, M.
    Rosti, G.
    HAEMATOLOGICA, 2013, 98 : 59 - 59
  • [38] The Impact of Early Molecular Response in Event Free Survival in Patients with Chronic Myeloid Leukemia Treated with Imatinib
    Fogliatto, Laura
    Zanella Capra, Marcelo Eduardo
    Shaan, Mariza
    Costa, Tito Vanelli
    Torriani, Mayde Seadi
    Zanandrea Contin, Luis Carlos
    Breunig, Raquel
    Fassina, Katia
    Fernandes, Mario Sergio
    Almeida, Denise
    Schilling, Marco Antonio
    Hellwig, Tania
    Daltoe, Tiago
    Zardo, Adriana
    Moschen, Mariangela
    Nene, Moema
    Silveira, Juarez Fontoura
    Soares, Tahiane Brum
    Daudt, Liane Esteves
    Friedrisch, Joao
    Silla, Lucia
    BLOOD, 2014, 124 (21)
  • [39] Monitoring disease response in chronic-phase chronic myeloid leukemia: the age of molecular assays?
    Yeung, David T.
    Branford, Susan
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2012, : 111 - 114
  • [40] Complete response to imatinib mesylate treatment in a 12-month-old patient with chronic myeloid leukemia
    Arancibia, Alejandro Mauricio
    Bendit, Israel
    Epelman, Sidnei
    Bendit, Israel
    PEDIATRIC BLOOD & CANCER, 2008, 50 (05) : 1078 - 1078
12345